文献速递艾滋病与性传播感染

启动抗逆转录病毒治疗后体重增加与后续代谢及心血管疾病风险

Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease.
PubMed 文献 · Clin Infect Dis · 2024-01-01

在ACTG参与者中评估启动ART后48周内体重变化与代谢指标变化及后续糖尿病、代谢综合征和心血管事件的关系。体重增加>10%者糖尿病、代谢综合征和心脏代谢结局风险升高,体重下降>5%者代谢综合征风险有降低趋势。

要点

  • 启动ART后0-48周平均体重增加3.6 kg(标准差7.3)。
  • 体重增加>10%者糖尿病风险HR 2.01,代谢综合征风险HR 2.24,心脏代谢结局风险HR 1.54。
  • 体重下降>5%者代谢综合征风险HR 0.67,95%CI跨1,未达统计学显著。

核心结论

  • 启动ART后第一年内体重和体成分变化与同期代谢参数变化及后续心脏代谢疾病相关。

研究设计与样本

  • 研究纳入ACTG参与者2624例,主要男性(81%)和非白人(60%),随访至480周。
  • 采用线性回归模型分析0-48周体重/腰围变化与0-48周及48-96周代谢参数变化的关系。
  • 采用Cox比例风险模型分析0-48周体重/腰围变化与48周后糖尿病、代谢综合征或心脏代谢及心血管事件的关系。

主要发现

  • 0-48周平均体重增加3.6 kg(标准差7.3);随访期间130例发生糖尿病,360例发生代谢综合征,424例发生任何心脏代谢事件,28例发生任何心血管事件。
  • 与体重变化-5%至5%者相比,体重增加>10%者糖尿病风险HR 2.01(95%CI 1.30-3.08),代谢综合征风险HR 2.24(95%CI 1.55-2.62),心脏代谢结局风险HR 1.54(95%CI 1.22-1.95)。
  • 基线体重下降>5%者发生代谢综合征的风险HR 0.67(95%CI 0.42-1.07)。
  • 腰围变化趋势与体重变化相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Weight gain following initiation of antiretroviral therapy (ART) is common. We assessed the impact of changes in weight in the year following ART initiation with subsequent cardiometabolic disease among AIDS Clinical Trials Group (ACTG) participants. METHODS: Linear regression models were fit to examine the association between change in weight/waist circumference (WC) in weeks 0-48 and change in metabolic parameters in weeks 0-48 and 48-96. Cox proportional hazard models were fit to examine the association between changes in weight/WC in weeks 0-48 and diabetes mellitus (DM), metabolic syndrome, or cardiometabolic and cardiovascular events after week 48. RESULTS: Participants (N = 2624) were primarily male (81%) and non-White (60%). Mean weight gain from 0-48 weeks was 3.6 kg (SD 7.3); 130 participants developed DM; 360 metabolic syndrome; 424 any cardiometabolic event; 28 any cardiovascular event, over 480 weeks of follow-up. In adjusted models, total cholesterol increased by 0.63 mg/dL (95% confidence interval [CI] [.38, .089]) and LDL by 0.39 mg/dL (0.19, 0.59) per 1 kg increase in weight from weeks 0 to48. Participants who experienced >10% weight gain (vs -5% to 5%) had an increased risk of DM (hazard ratio [HR] 2.01, 95% CI [1.30, 3.08]), metabolic syndrome (HR 2.24, 95% CI [1.55, 2.62]), and cardiometabolic outcomes (HR 1.54, 95% CI [1.22, 1.95]). Participants who lost more than 5% of their baseline weight had a lower risk of incident metabolic syndrome (HR 0.67, 95% CI [0.42, 1.07]). Trends for WC were similar. CONCLUSIONS: Weight and body composition changes in the first year following ART initiation are associated with contemporaneous changes in metabolic parameters and subsequent cardiometabolic disease.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Bares SH, Wu X, Tassiopoulos K, et al. Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease. Clin Infect Dis. 2024. PMID: 37698083. doi:10.1093/cid/ciad545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。